Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
Hemasphere. 2023 Nov 17;7(12):e983.
doi: 10.1097/HS9.0000000000000983.
eCollection 2023 Dec.